These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Agranulocytosis, thrombocytopenia, and procainamide. Christensen DJ; Palma LF; Phelps K Ann Intern Med; 1984 Jun; 100(6):918. PubMed ID: 6721310 [No Abstract] [Full Text] [Related]
24. Agranulocytosis following procainamide administration. Wang RI; Schuller G Am Heart J; 1969 Aug; 78(2):282-4. PubMed ID: 5797276 [No Abstract] [Full Text] [Related]
25. Agranulocytosis due to new sustained-release procainamide. Berger BE; Hauser DJ Am Heart J; 1983 Jun; 105(6):1035-6. PubMed ID: 6858823 [No Abstract] [Full Text] [Related]
26. Agranulocytosis in a 12-year-old girl treated with procainamide. Gunay U; Honig GR Clin Pediatr (Phila); 1974 Sep; 13(9):728-30. PubMed ID: 4411903 [No Abstract] [Full Text] [Related]
27. Reversible severe anaemia and granulocytopenia caused by procainamide. A case report. van Beek RJ; Bieger R; den Ottolander GJ Scand J Haematol; 1978 Aug; 21(2):150-2. PubMed ID: 694426 [TBL] [Abstract][Full Text] [Related]
28. Correction: procainamide versus Procan SR. Boros L N Y State J Med; 1985 Oct; 85(10):611. PubMed ID: 3866171 [No Abstract] [Full Text] [Related]
29. [Drug-induced agranulocytosis with bone marrow plasmocytic proliferation]. Farquet JJ; Girard JP; Ritter O; Miescher PA Ther Umsch; 1971 Sep; 28(9):606-11. PubMed ID: 5122523 [No Abstract] [Full Text] [Related]
30. [Role of various drugs in the activation of systemic lupus erythematosus]. Alarcón Segovia D Rev Invest Clin; 1966; 18(3):445-66. PubMed ID: 4867683 [No Abstract] [Full Text] [Related]
31. Reversible procainamide-induced agranulocytosis twice in one patient. Konttinen YP; Tuominen L Lancet; 1971 Oct; 2(7730):925. PubMed ID: 4106683 [No Abstract] [Full Text] [Related]
32. Unusual reactions to common cardiovascular drugs. Harrison CE; Davies NE J Med Assoc Ga; 1970 Mar; 59(3):117-20. PubMed ID: 4244567 [No Abstract] [Full Text] [Related]
33. Procainamide and neutropenia. Ann Intern Med; 1984 May; 100(5):766-7. PubMed ID: 6712043 [No Abstract] [Full Text] [Related]
34. Drug fever due to procainamide. Pierach CA Minn Med; 1969 May; 52(5):813-6. PubMed ID: 5797616 [No Abstract] [Full Text] [Related]
35. Severe neutropenia associated with procainamide: comparison of sustained release and conventional preparations. Meyers DG; Gonzalez ER; Peters LL; Davis RB; Feagler JR; Egan JD; Nair CK Am Heart J; 1985 Jun; 109(6):1393-5. PubMed ID: 4003250 [No Abstract] [Full Text] [Related]
36. Administration of filgrastim in two patients with drug-induced agranulocytosis. Castanheira D; Marzella M; Skirvin JA Pharmacotherapy; 1998; 18(6):1347-51. PubMed ID: 9855337 [TBL] [Abstract][Full Text] [Related]
37. Neutropenia and procainamide. Katkov W; Ellrodt AG Am Heart J; 1985 Dec; 110(6):1321-2. PubMed ID: 4072899 [No Abstract] [Full Text] [Related]
38. Mania associated with procainamide. Rice H; Haltzman S; Tucek C Am J Psychiatry; 1988 Jan; 145(1):129-30. PubMed ID: 3337281 [No Abstract] [Full Text] [Related]
39. Sustained-release procainamide and neutropenia. Anderson S; Wenger NK Ann Intern Med; 1984 Sep; 101(3):404. PubMed ID: 6465719 [No Abstract] [Full Text] [Related]
40. [Therapy and prophylaxis of contrast media incidents]. Just OH Rontgenpraxis; 1972 May; 25(5):102-7. PubMed ID: 5047505 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]